Claritev Q1 revenue beats estimates, lifts 2026 outlook

Claritev

Claritev

CTEV

0.00


Overview

  • US healthcare data platform's Q1 revenue rose 5.8%, beating analyst expectations

  • Q1 adjusted EBITDA increased 3.4% and slightly beat analyst expectations

  • Company raised 2026 revenue guidance, kept other outlook metrics unchanged


Outlook

  • Claritev raises 2026 revenue guidance to $985 mln-$1 bln from $980 mln-$1 bln

  • Company maintains 2026 Adjusted EBITDA guidance at $605 mln-$615 mln

  • Claritev expects continued growth from expansion into provider and government verticals


Result Drivers

  • CORE BUSINESS CONSISTENCY - Co said consistent performance in its core business drove Q1 revenue and adjusted EBITDA growth

  • EXPANSION INTO NEW VERTICALS - Co cited growth from expansion into provider and government verticals, leading to more diversified revenue streams

  • AI APPLICATIONS - Co said differentiated application of AI is helping accelerate progress and support growth


Company press release: ID:nBw6JTc60a


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$244.68 mln

$236.39 mln (3 Analysts)

Q1 Net Income

-$73.56 mln

Q1 Adjusted EBITDA

Slight Beat*

$146.90 mln

$145.50 mln (4 Analysts)

Q1 Operating Income

Miss

$6.64 mln

$17.77 mln (1 Analyst)

Q1 Pretax Profit

Miss

-$92.72 mln

-$91.01 mln (2 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.